Gimv is a European investment company with over 38 years’ experience in private equity and venture capital. The company is listed on Euronext Brussels. Gimv currently manages around 1.6 billion EUR of investments in about 50 portfolio companies, jointly realising a turnover of about 2 billion EUR and employing over 13 000 professionals.

As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s four investment platforms are: Connected Consumer, Health & Care, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts.

Latest Gimv news

  1. Increase in acquisition prices in Belgium has come to a standstill

    Date: 16/05/2019
    It appears the merger and acquisition market in Belgium has reached its turning point. For the first time in six years, the sustained rise in acquisition prices has not continued. However the number of transactions did continue to grow, even though there were considerably fewer foreign acquisitions in 2018. Another striking point is that the acquisition of technology and attraction of talent are gaining importance as motivations for an acquisition. Finally, when it comes to the size of transactions, smaller acquisition deals are on the increase. These are the most important conclusions of the sixth edition of the M&A Monitor, an annual survey of more than 150 Belgian merger and acquisition specialists.
    Read More
  2. Acquisition prices in Belgium reach absolute record heights

    Date: 07/06/2018
    The Belgian mergers and acquisitions market gradually seems to be reaching its peak. It is not just the number of transactions but also the selling prices which rose for the fifth year in a row in 2017. The highest valuations are found in the real estate sector followed by pharmaceuticals, technology and healthcare. The demand is greater than the supply and competition is increasing. In addition, more and more foreign players are showing an interest in Belgian companies. In view of the anticipated further growth in 2018, there is a danger of overheating. These are the main conclusions of the M&A Monitor, an annual survey which involves over 150 Belgian mergers and acquisitions experts and advisers.
    Read More
  3. Investing in healthcare: 3 growth stories

    Date: 20/04/2018
    At the latest Healthcare Innovation boot camp, Bart Diels, Head of Health & Care at Gimv, gave a guest lecture on how the investment company guides healthcare players along their growth path, based on its own strategy and specific Health & Care strategy. Three different players, three different growth stories: ‘buy-and-build’, ‘hub-and-spoke’ and international expansion. Our students asked pertinent questions.
    Read More
  4. “A Trojan horse? No thanks!”

    Date: 07/02/2018
    Many family businesses aren't making full use of the potential of private equity. Is it because they fear what they don't know? Or are they worried that bringing a financial investor on board will be like inviting in a Trojan horse? A ‘meeting of minds’ between Professors Sophie Manigart and Miguel Meuleman, Dr. Jeroen Neckebrouck and Koen Dejonckheere, the CEO of investment company Gimv.
    Read More
  5. Belgian companies more frequently taken over by foreign players

    Date: 08/06/2017
    In contrast to a decreasing trend on the international mergers and acquisitions market in 2016, the Belgian M&A market has experienced further growth, particularly with regard to medium-sized and smaller deals. The demand exceeds the supply. Although transaction prices are rising, they are still acceptable. Anyone wishing to sell a profitable business these days can easily find a buyer. This can be explained by the fact that bank financing has become easier, as well as increased interest by foreign players in Belgian companies.
    Read More
  6. “Look beyond the figures”

    Date: 14/02/2017
    Professor Robert Boute invited Bart Cauberghe, Managing Partner & Head Smart Industries from our Chair Partner Gimv, to present the Punch Powertrain project to our full-time MBA students on 17 January. During a 90-minute lecture Bart took his audience on a bumpy and at times hilarious journey, explaining how in just seven years a low-performing supplier of automatic transmissions was turned into a highly attractive company worth 1 billion euros. “Not by financial ‘tricks’, but by operational improvements.”
    Read More
  7. Strong growth in Belgian mergers and acquisitions market

    Date: 29/09/2016
    2015 and the beginning of 2016 were characterised by a pronounced increase in the number of transactions in the Belgian mergers and acquisitions market. Demand is greater than supply, stimulated by easy and cheap access to finance and greater availability of financial resources to investment companies. Furthermore, the persistently low interest rate environment means there is increased interest from family investors, wealthy individuals and foreign private equity funds in Belgian medium-size enterprises. It is therefore not surprising that the prices paid are increasing across all sectors and business sizes. These are the findings from a survey of 142 Belgian mergers and acquisitions experts into their experiences over the past year.
    Read More
  8. Optimist or opportunist?

    Date: 14/06/2016
    Recent research by Veroniek Collewaert, Professor of Entrepreneurship, has shown that entrepreneurs’ over-optimism towards a possible investor cannot always be put down to an ‘enthusiastic belief in their business’. Sometimes prognoses are deliberately presented in an excessively rosy light. Peter Maenhout, the Head Connected Consumer at our Chair Partner Gimv, the regional investment company in Flanders, explains: ‘Just give us the “raw data” of an entrepreneur who knows his market.’
    Read More
All Partners news

& Rankings

Equis Association of MBAs AACSB Financial Times